[Evaluation of satisfaction with telemedicine devices and with the results of the care received among chronic patients. The ValCrònic program]. / Evaluación de la satisfacción de los pacientes crónicos con los dispositivos de telemedicina y con el resultado de la atención recibida. Programa ValCrònic.

OBJECTIVE: To evaluate patient satisfaction with the ValCrònic program, telemedicine devices, and the results of the care received after a 2-year follow-up. DESIGN: Observational, descriptive study based on telephone surveys. SETTING: The autonomous community of Valencia (Spain). PARTICIPANTS: Participants consisted of 410 patients with one or more of the following diseases: hypertension, heart failure, diabetes, or chronic obstructive pulmonary disease. A total of 585 patients were included, of whom 104 left the program (18 due to death) and 71 refused to participate. METHODS: We designed and validated a specific scale. Floor and ceiling effects were considered. Internal consistency was analyzed using Cronbach's alpha. RESULTS: Responses were obtained from 322 patients (response rate, 78.5%). Of these, 118 (36.6%) were women. In 48 patients (14.9%), the person responding was a caregiver. Cronbach's alpha was 0.7. For 278 patients (86.3%), the ValCrònic program helped them to understand their disease better, 270 (83.9%) reported that it helped them use their medication more safely, and 283 (87.9%) reported they had better knowledge of their disease. For 288 (89.4%), the devices were easy to manage at home. Only 12 patients (3.7%) found that the devices involved a heavy workload that was difficult to incorporate into their daily lives. CONCLUSIONS: The ValCrònic program promotes self-care among patients.

Evaluación de la satisfacción de los pacientes crónicos con los dispositivos de telemedicina y con el resultado de la atención recibida. Programa ValCrònic / Evaluation of satisfaction with telemedicine devices and with the results of the care received among chronic patients. The ValCrònic program

OBJETIVO: Evaluar la satisfacción de los pacientes con el programa ValCrònic, los dispositivos de telemedicina y con el resultado de la atención recibida tras 2 años de seguimiento. DISEÑO: Estudio observacional descriptivo basado en encuestas telefónicas. Emplazamiento: Comunidad Valenciana. Participantes: En total participaron 410 pacientes que presentaban una o varias de las siguientes patologías: hipertensión, insuficiencia cardíaca, diabetes o enfermedad pulmonar obstructiva crónica. Se incluyó a 585 pacientes, de los cuales 104 abandonaron el programa (18 por fallecimiento) y 71 rehusaron participar. MÉTODOS: Se diseñó y validó una escala específica. Se consideraron los efectos techo y suelo. Se analizó la consistencia interna mediante alfa de Cronbach. Para comprobar la validez de constructo se empleó un análisis exploratorio de componentes principales con criterio de autovaloración igual a 1. Se aplicó el procedimiento de rotación Varimax. Se consideraron como pérdidas aceptables de información cargas factoriales ≥ 0,55. La escala se conformó con 7 preguntas cerradas y 1 abierta. RESULTADOS: Respondieron un total de 322 pacientes (tasa de respuesta del 78,5%). 118 (36.6%) fueron mujeres. En 48 (14,9%) casos respondió un cuidador. El valor del alfa de Cronbach fue de 0,7. ValCrònic supuso para 278 (86,3%) pacientes una ayuda para conocer mejor su enfermedad, 270 (83,9%) afirmaron hacer un uso más seguro de la medicación gracias a ValCrònic y 283 (87,9%) dijeron conocer ahora mejor su enfermedad. Para 288 (89,4%) los dispositivos fueron fáciles de manejar en casa. Solo en 12 (3,7%) casos el paciente consideró que los dispositivos de telemedicina suponían una carga de trabajo difícil de conciliar en su día a día. CONCLUSIONES: ValCrònic ha contribuido a la activación de los pacientes para autocuidado

OBJECTIVE: To evaluate patient satisfaction with the ValCrònic program, telemedicine devices, and the results of the care received after a 2-year follow-up. DESIGN: Observational, descriptive study based on telephone surveys. Setting: The autonomous community of Valencia (Spain). Participants: Participants consisted of 410 patients with one or more of the following diseases: hypertension, heart failure, diabetes, or chronic obstructive pulmonary disease. A total of 585 patients were included, of whom 104 left the program (18 due to death) and 71 refused to participate. METHODS: We designed and validated a specfic scale. Floor and ceiling effects were considered. Internal consistency was analyzed using Cronbach's alpha. RESULTS: Responses were obtained from 322 patients (response rate, 78.5%). Of these, 118 (36.6%) were women. In 48 patients (14.9%), the person responding was a caregiver. Cronbach's alpha was 0.7. For 278 patients (86.3%), the ValCrònic program helped them to understand their disease better, 270 (83.9%) reported that it helped them use their medication more safely, and283 (87.9%) reported they had better knowledge of their disease. For 288 (89.4%), the devices were easy to manage at home. Only 12 patients (3.7%) found that the devices involved a heavy workload that was difficult to incorporate into their daily lives. CONCLUSIONS: The ValCrònic program promotes self-care among patients